Addressing The Role of Nutrition Education & Health Literacy in Diabetes Care

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00715585

Acronym

DiNES

Enrollment

150

Registered

2008-07-15

Start date

2008-06-30

Completion date

2010-06-30

Last updated

2013-06-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Keywords

diabetes, education, health literacy

Brief summary

This study examines the impact of certified diabetes education, and the role of different educational approaches to medical nutrition therapy. in addition the role of patient health literacy level is assessed

Detailed description

150 patients with type 2 diabetes with most recent a1c\>7% will be enrolled. patients are randomized to three arms: arm 1 includes 3 individualized visits with an rd-cde focused on a modified plate method for nutrition therapy, arm 2 includes 3 individualized visits with an rd-cde focused on carb counting for nutrition therapy, and arm 3 focuses on general diabetes education and health promotion. education sessions will be administered over a 4-6 week period. patients will be assessed at baseline, 3 and 6 month follow-up. primary outcome is a1c.

Interventions

BEHAVIORALActive Control

patients receive 3 individualized visits with a health educator focused on general diabetes education and health promotion

BEHAVIORALint arm 1

VVpatients receive 3 individualized visits with an rd-cde for education focused on modified plate method

BEHAVIORALint arm 3

patients receive 3 individualized visits with an rd-cde for education focused on carb counting

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 90 Years

Healthy volunteers

Yes

Inclusion criteria

* Most recent a1c \>7 * Type 2 diabetes * Receiving primary care * Not currently in the diabetes improvement program * No plans to refer to diabetes improvement program in the next 6 mos

Exclusion criteria

* Significant dementia or psychosis

Design outcomes

Primary

Measure	Time frame
A1C	6 months

Secondary

Measure	Time frame
self-efficacy	3 and 6 months
satisfaction	3 and 6 months
dietary behavior	6 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026